Source: International Congress 2019 – Airway diseases and blood cells
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Biondini (Padova, Italy), U. Semenzato (Padova, Italy), M. Bonato (Padova, Italy), M. Tinè (Padova, Italy), E. Bazzan (Padova, Italy), M. Damin (Padova, Italy), G. Turato (Padova, Italy), J. Marin (Zaragoza, Spain), M. Cosio (Montreal, Canada), M. Saetta (Padova, Italy). Lymphopenia is linked to an increased incidence of cancer in smokers without COPD. 2586

Member's Comments

No comment yet.

Related content which might interest you: COPD and lung cancer incidence in never smokers Source: International Congress 2019 – Asthma and COPD comorbidities Year: 2019 The prevalence of undiagnosed COPD and approaches to promote early COPD diagnosis in lung cancer population Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 COPD in patients with lung cancer and smoking Source: Eur Respir J 2005; 26: Suppl. 49, 519s Year: 2005 Reduced FEV3/FVC identifies smokers at risk of developing COPD in the SPIROMICS cohort Source: International Congress 2018 – Respiratory muscles and lung function: from healthy subjects to patients Year: 2018 Interstitial lung abnormalities in smokers are associated with increased mortality Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Incidence of lung cancer among COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 494s Year: 2005 Budesonide is not associated with increased risk of pneumonia in COPD patients Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 What is real prevalence of COPD in patients with lung cancer? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer? Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 COPD prevalence is increased in lung cancer, independent of age, sex and smoking history Source: Eur Respir J 2009; 33: 380-386 Year: 2009 COPD, asthma, and lung cancer patients Source: International Congress 2016 – ME13 Smoking cessation in difficult population groups Year: 2016 Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 Poor self regulation correlates with the incidence of lung cancer in smokers Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis Year: 2017 Evidence for harm reduction in diseased smokers Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited Year: 2007 Quantification of smokers and smoking status among COPD patients, hospitalized for an exacerbation Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 The effect of smoking on exacerbation risk in eosinophilic patients with COPD Source: Eur Respir J, 50 (6) 1701820; 10.1183/13993003.01820-2017 Year: 2017 The effect of smoking on exacerbation risk in eosinophilic patients with COPD Source: Eur Respir J, 50 (6) 1702086; 10.1183/13993003.02086-2017 Year: 2017 Increased relative mortality in women with severe oxygen-dependent COPD Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010